Forkhead L2 Is Expressed in the Ovary and Represses the Promoter Activity of the Steroidogenic Acute Regulatory Gene
Authors:
- 1 July 2004
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 145 (7) , 3424-3433
Abstract
Premature ovarian failure in a subgroup of women with blepharophimosis-ptosis-epicanthus inversus type 1 syndrome has been associated with nonsense mutations in the gene encoding a Forkhead transcription factor, Forkhead L2 (FOXL2). However, the exact function of FOXL2 in the ovary is unclear. We investigated the expression of FOXL2 in the mouse ovary during follicular development and maturation by RT-PCR and in situ hybridization. The FOXL2 mRNA is expressed in ovaries throughout development and adulthood and is localized to the undifferentiated granulosa cells in small and medium follicles as well as cumulus cells of preovulatory follicles. FOXL2 belongs to a group of transcription factors capable of interacting with specific DNA sequences in diverse gene promoters. With the presence of multiple putative forkhead DNA consensus sites, the promoter of the human steroidogenic acute regulatory (StAR) gene was used to test for regulation by FOXL2. Cotransfection studies revealed that wild-type FOXL2 represses the activity of the StAR promoter, and the first 95 bp upstream of the transcriptional start site of the StAR gene is sufficient for FOXL2 repression. EMSAs confirmed that FOXL2 interacts directly with this region. Analyses using FOXL2 mutants also demonstrated the importance of the entire alanine/proline-rich carboxyl terminus of FOXL2 for transcriptional repression. Furthermore, these mutations produce a protein with a dominant-negative effect that disables the transcriptional repressor activity of wild-type FOXL2. Dominant-negative mutations of FOXL2 could increase expression of StAR and other follicle differentiation genes in small and medium follicles to accelerate follicle development, resulting in increased initial recruitment of dormant follicles and thus the premature ovarian failure phenotype.Keywords
This publication has 76 references indexed in Scilit:
- The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenanceDevelopment, 2004
- Suppression of Ovarian Follicle Activation in Mice by the Transcription Factor Foxo3aScience, 2003
- Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cellsCancer, 2003
- MLL-AFX Requires the Transcriptional Effector Domains of AFX To Transform Myeloid Progenitors and Transdominantly Interfere with Forkhead Protein FunctionMolecular and Cellular Biology, 2002
- Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian familiesAmerican Journal of Medical Genetics, 2002
- CCAAT Enhancer-binding Protein β and GATA-4 Binding Regions within the Promoter of the Steroidogenic Acute Regulatory Protein (StAR) Gene Are Required for Transcription in Rat Ovarian CellsJournal of Biological Chemistry, 1999
- Steroidogenic Factor 1-Dependent Promoter Activity of the Human Steroidogenic Acute Regulatory Protein (StAR) GeneBiochemistry, 1996
- Role of Steroidogenic Acute Regulatory Protein in Adrenal and Gonadal SteroidogenesisScience, 1995
- DNA recognition site analysis of Xenopus wingedhelix proteinsJournal of Molecular Biology, 1995
- Distribution of binding sites for human chorionic gonadotropin in the preovulatory follicle of the rat.Journal of Cell Biology, 1975